Physician profile
Arun P Venkat
NPI 1952436354
$2,076.64
in general payments reported to CMS, 2019-2025
23 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $130 · 2021: $194 · 2022: $218 · 2023: $260 · 2024: $650 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $342.82 | 2019-2025 | Nemluvio |
| Abbvie INC. | $259.24 | 2022-2025 | Rinvoq, Skyrizi |
| Regeneron Healthcare Solutions, INC. | $175.06 | 2023-2025 | Libtayo |
| Janssen Biotech, INC. | $168.41 | 2021-2024 | Tremfya |
| Almirall LLC | $154.16 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $141.69 | 2024-2025 | |
| Leo Pharma INC. | $140.22 | 2024-2025 | Adbry |
| Pfizer INC. | $116.30 | 2019-2022 | |
| Genzyme Corporation | $106.26 | 2022-2025 | |
| Lilly USA, LLC | $75.96 | 2021-2022 | |
| Dermavant Sciences, INC. | $61.49 | 2022-2024 | Vtama |
| Allergan, INC. | $46.94 | 2019 | |
| Ucb, INC. | $46.31 | 2021-2023 | Cimzia |
| Sanofi-Aventis U.S. LLC | $44.39 | 2021 | |
| Incyte Corporation | $41.86 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $32.05 | 2023 | Sotyktu |
| Biofrontera INC. | $31.28 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $31.25 | 2024 | Tremfya |
| Sun Pharmaceutical Industries INC. | $21.67 | 2019 | |
| Strata Skin Sciences, INC. | $16.11 | 2025 | Xtrac |
| Sensus Healthcare, INC. | $14.72 | 2019 | |
| Organon LLC | $8.45 | 2025 | Vtama |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Venkat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.